[go: up one dir, main page]

ITMI912261A0 - Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego - Google Patents

Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego

Info

Publication number
ITMI912261A0
ITMI912261A0 IT91MI2261A ITMI912261A ITMI912261A0 IT MI912261 A0 ITMI912261 A0 IT MI912261A0 IT 91MI2261 A IT91MI2261 A IT 91MI2261A IT MI912261 A ITMI912261 A IT MI912261A IT MI912261 A0 ITMI912261 A0 IT MI912261A0
Authority
IT
Italy
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
containing clozapine
clozapine
Prior art date
Application number
IT91MI2261A
Other languages
English (en)
Inventor
Volker Fischer
Ronald Paul Mason
Original Assignee
Sandoz Sa
Us Commerce
Sandoz Ag
Usa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa, Us Commerce, Sandoz Ag, Usa filed Critical Sandoz Sa
Publication of ITMI912261A0 publication Critical patent/ITMI912261A0/it
Publication of ITMI912261A1 publication Critical patent/ITMI912261A1/it
Application granted granted Critical
Publication of IT1251226B publication Critical patent/IT1251226B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ITMI912261A 1990-08-20 1991-08-20 Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego IT1251226B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56968990A 1990-08-20 1990-08-20
US71713691A 1991-06-18 1991-06-18

Publications (3)

Publication Number Publication Date
ITMI912261A0 true ITMI912261A0 (it) 1991-08-20
ITMI912261A1 ITMI912261A1 (it) 1993-02-20
IT1251226B IT1251226B (it) 1995-05-05

Family

ID=27075116

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912261A IT1251226B (it) 1990-08-20 1991-08-20 Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego

Country Status (30)

Country Link
US (2) US5312819A (it)
JP (1) JPH0813745B2 (it)
KR (1) KR100189349B1 (it)
AT (1) AT400522B (it)
AU (1) AU649269B2 (it)
BE (1) BE1006878A5 (it)
CA (1) CA2065421A1 (it)
CH (1) CH684162A5 (it)
CZ (1) CZ281843B6 (it)
DE (1) DE4191979T (it)
DK (1) DK51292D0 (it)
ES (1) ES2078838B1 (it)
FI (1) FI913888A7 (it)
FR (1) FR2665835B1 (it)
GB (1) GB2254252B (it)
GR (1) GR1002188B (it)
HU (1) HUT60137A (it)
IE (1) IE66121B1 (it)
IL (1) IL99224A (it)
IT (1) IT1251226B (it)
LU (1) LU88099A1 (it)
MX (1) MX9100742A (it)
MY (1) MY107976A (it)
NL (1) NL9120006A (it)
NZ (1) NZ239464A (it)
PT (1) PT98707B (it)
RU (1) RU2080860C1 (it)
SE (1) SE9201189D0 (it)
SK (1) SK279225B6 (it)
WO (1) WO1992003138A1 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2935292A (en) * 1991-10-31 1993-06-07 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Prevention of drug-induced agranulocytosis with free radical scavengers
US5538965A (en) * 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
CA2167104A1 (en) * 1995-01-17 1996-07-18 Joerg G.D. Birkmayer Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration
JP3889481B2 (ja) * 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
WO1999021422A1 (en) * 1997-10-27 1999-05-06 Cortex Pharmaceuticals, Inc. Treatment of schizophrenia with ampakines and neuroleptics
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
JP2003026567A (ja) * 2001-05-10 2003-01-29 Kanegafuchi Chem Ind Co Ltd 補酵素ｑを有効成分とする粘膜投与用組成物
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
AU2008359725A1 (en) * 2008-07-24 2010-01-28 Handa Pharmaceuticals, Llc Stabilized atypical antipsychotic formulation
RU2441651C1 (ru) * 2010-12-23 2012-02-10 Маргарита Алексеевна Морозова Способ получения фармацевтической композиции клозапина в виде таблеток и фармацевтическая композиция
RU2610169C2 (ru) 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" ПРОИЗВОДНЫЕ 7-ФТОРО-8-ХЛОРО-5Н-ДИБЕНЗО[b, е][1, 4]ДИАЗЕПИНА И ИХ ПРИМЕНЕНИЕ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI50242C (fi) * 1969-07-18 1976-01-12 Thomae Gmbh Dr K Menetelmä valmistaa farmakologisesti aktiivisia uusia diallyyliaminoal kanoyylidibenso- tai pyridobenso-diatsepiineja ja niiden happoadditios uoloja.
US3983234A (en) * 1974-07-04 1976-09-28 Sandoz Ltd. Treatment of dyskinesias
US4028467A (en) * 1975-01-07 1977-06-07 Berger Frank M Analgesic compositions comprising levo-propoxyphene and benzo diazepine and process
GB1498857A (en) * 1975-07-03 1978-01-25 Leo Ab Antidepressant composition
EP0026469B1 (en) * 1979-10-01 1984-11-28 Sandoz Ag Dibenzazepine derivatives, their production and pharmaceutical compositions containing them
US4761411A (en) * 1983-05-18 1988-08-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses
DE3542309A1 (de) * 1985-11-29 1987-06-04 Cardona Federico Dr Medizinisches antioxidativum
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
US4996199A (en) * 1988-04-08 1991-02-26 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物

Also Published As

Publication number Publication date
AT400522B (de) 1996-01-25
SE9201189L (sv) 1992-04-14
FI913888L (fi) 1992-02-21
NL9120006A (nl) 1992-08-03
ITMI912261A1 (it) 1993-02-20
MY107976A (en) 1996-07-15
BE1006878A5 (fr) 1995-01-17
DK51292A (da) 1992-04-15
CA2065421A1 (en) 1992-02-21
FR2665835B1 (fr) 1995-06-23
SE9201189D0 (sv) 1992-04-14
PT98707B (pt) 1999-01-29
KR100189349B1 (en) 1999-06-01
HUT60137A (en) 1992-08-28
FI913888A7 (fi) 1992-02-21
GB2254252A (en) 1992-10-07
US5312819A (en) 1994-05-17
DE4191979T (it) 1992-10-08
ES2078838B1 (es) 1997-02-01
US5563134A (en) 1996-10-08
HU9201090D0 (en) 1992-06-29
IE66121B1 (en) 1995-12-13
FR2665835A1 (fr) 1992-02-21
MX9100742A (es) 1992-04-01
NZ239464A (en) 1993-10-26
IL99224A0 (en) 1992-07-15
SK279225B6 (sk) 1998-08-05
AU8396391A (en) 1992-03-17
LU88099A1 (de) 1992-11-16
CZ281843B6 (cs) 1997-02-12
JPH05503296A (ja) 1993-06-03
IT1251226B (it) 1995-05-05
IL99224A (en) 1996-01-31
IE912934A1 (en) 1992-02-26
AU649269B2 (en) 1994-05-19
GR1002188B (en) 1996-03-13
KR920702225A (ko) 1992-09-03
ATA900491A (de) 1995-06-15
JPH0813745B2 (ja) 1996-02-14
RU2080860C1 (ru) 1997-06-10
GB9206101D0 (en) 1992-06-24
DK51292D0 (da) 1992-04-15
GB2254252B (en) 1994-06-01
FI913888A0 (fi) 1991-08-16
PT98707A (pt) 1992-07-31
ES2078838A1 (es) 1995-12-16
GR910100361A (el) 1992-08-31
CS55092A3 (en) 1992-08-12
WO1992003138A1 (en) 1992-03-05
CH684162A5 (de) 1994-07-29

Similar Documents

Publication Publication Date Title
FI934274A7 (fi) N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset
FI922958L (fi) Farmaceutisk sammansaettning
FI981777A0 (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
FI925661L (fi) Injicerbar farmaceutisk komposition
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
FI941836A7 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
MX9200622A (es) Composicion farmaceutica
FI950290A7 (fi) Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö
FI943645A7 (fi) Uusia bakkatiini-III ja 10-deasetyylibakkatiini-III-johdannaisia, niid en valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI910088L (fi) Oral farmaceutisk komposition.
ITMI912261A1 (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
FI943294L (fi) Alkaloidit Mappia foetidasta, niiden käyttö, ja niitä sisältävät formulloinnit
UA26064A1 (uk) Фармацевтичhа композиція
FI921876A7 (fi) Farmaseuttinen koostumus, joka sisältää diritromysiiniä
FI941517A7 (fi) Bentsonaftyridiinin-1,8 johdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
IT1243798B (it) Composti aromatici contenenti gruppi solfo, loro preparazione e loro impiego
FI962979L (fi) Hirudiinia sisältävät farmaseuttiset koostumukset
ITMI912290A0 (it) Miscele di n-alchilftalimmidi, loro preparazione e loro impiego
FI910773A7 (fi) Episialo-hiilihydraattikompleksia sisältävä farmaseuttinen koostumus
FI930967A7 (fi) Substituoituja 6,7-dihydroimidatso(1,5,4-ef)(1,5)bentsodiatsepin-6-one ja, niiden valmistus ja farmaseuttiset koostumukset
FI911084A7 (fi) 5-fenyyli-1H-pyrazoli-4-propionihappojohdannaisia, niiden valmistus jakäyttö

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970714